Abstract:Neurological diseases have consistently represented a significant challenge in both clinical treatment and scientific research. As research has progressed, the significance of mitochondria in the pathogenesis and progression of neurological diseases has become increasingly prominent. Mitochondria serve not only as a source of energy, but also as regulators of cellular growth and death. Both oxidative stress and mitophagy are intimately associated with mitochondria, and there is mounting evidence that mitophagy and oxidative stress exert a pivotal regulatory influence on the pathogenesis of neurological diseases. In recent years, there has been a notable rise in the prevalence of cerebral ischemia/reperfusion injury (CI/RI), vascular dementia (VaD), and Alzheimer's disease (AD), which collectively represent a significant public health concern. Reduced levels of mitophagy have been observed in CI/RI, VaD and AD. The improvement of associated pathology has been demonstrated through the increase of mitophagy levels. CI/RI results in cerebral tissue ischemia and hypoxia, which causes oxidative stress, disruption of the blood-brain barrier (BBB) and damage to the cerebral vasculature. The BBB disruption and cerebral vascular injury may induce or exacerbate VaD to some extent. In addition, inadequate cerebral perfusion due to vascular injury or altered function may exacerbate the accumulation of amyloid β (Aβ) thereby contributing to or exacerbating AD pathology. Intravenous tissue plasminogen activator (tPA; alteplase) and endovascular thrombectomy are effective treatments for stroke. However, there is a narrow window of opportunity for the administration of tPA and thrombectomy, which results in a markedly elevated incidence of disability among patients with CI/RI. It is regrettable that there are currently no there are still no specific drugs for VaD and AD. Despite the availability of the U.S. Food and Drug Administration (FDA)-approved clinical first-line drugs for AD, including memantine, donepezil hydrochloride, and galantamine, these agents do not fundamentally block the pathological process of AD. In this paper, we undertake a review of the mechanisms of mitophagy and oxidative stress in neurological disorders, a summary of the clinical trials conducted in recent years, and a proposal for a new strategy for targeted treatment of neurological disorders based on both mitophagy and oxidative stress.

Progress in the regulatory mechanism of mitophagy in chronic cerebral ischemic neuronal injury

Research progress of mitophagy in chronic cerebral ischemia

Autophagy in Cerebral Ischemia: Progress and Challenge

A Novel Link Between Silent Information Regulator 1 and Autophagy in Cerebral Ischemia-Reperfusion

Mitophagy in Cerebral Ischemia and Ischemia/Reperfusion Injury

Targeting neuronal mitophagy in ischemic stroke: an update

Mitochondrial Fusion and Fission in Neuronal Death Induced by Cerebral Ischemia-Reperfusion and Its Clinical Application: A Mini-Review

Mitophagy in acute central nervous system injuries: regulatory mechanisms and therapeutic potentials

Contribution and therapeutic value of mitophagy in cerebral ischemia-reperfusion injury after cardiac arrest

Insight into Crosstalk Between Mitophagy and Apoptosis/Necroptosis: Mechanisms and Clinical Applications in Ischemic Stroke

The critical roles of mitophagy in cerebral ischemia

Mechanisms and therapeutic targets of mitophagy after intracerebral hemorrhage

Mitochondrial Quality Control in Cerebral Ischemia–Reperfusion Injury

The Role of Mitophagy in Ischemic Stroke

Signaling Pathways in Brain Ischemia: Mechanisms and Therapeutic Implications.

[Research advances in prevention and treatment of cerebral ischemia-reperfusion injury by targeting mitochondrial quality control]

Neuronal Injury in Rat Model of Permanent Focal Cerebral Ischemia is Associated with Activation of Autophagic and Lysosomal Pathways.

Mechanisms of mitophagy and oxidative stress in cerebral ischemia-reperfusion, vascular dementia, and Alzheimer's disease

Mitophagy in intracerebral hemorrhage: a new target for therapeutic intervention

Targeting the multifaceted roles of mitochondria in intracerebral hemorrhage and therapeutic prospects

Mitophagy, a potential therapeutic target for stroke